Skip to main content

3D Protein Structure Analysis Market Size, Share, Growth, Industry Analysis and Forecast 2022-2032

 One of the primary objectives of molecular biology research is to identify the structure of proteins. Protein complex analysis requires a thorough research of proteins' structure and function because they are found in complicated biological samples. The structure of protein complexes can be ascertained using contemporary protein complex analysis methods. Many studies are currently being conducted employing cryo-electron microscopy (EM), small angle X-ray scattering (SAXS), nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography to describe and understand molecular structures and molecular recognition mechanisms. Equipment for 3D protein structure analysis is available from reputable manufacturers including Bruker Corporation, JEOL Ltd., and Spectris plc depending on what is required. These tools can meet the laboratory's throughput requirements.

In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032. The growth in the global 3D protein structure analysis market is expected to be driven by technological advancements in equipment for protein structure analysis and by an increase in RD expenditure to accelerate protein structure analysis.

3D Protein Structure Analysis Market

Impact

•   The presence of major equipment providers of 3D protein structure analysis has a major impact on the market. For instance, in April 2022, NJ Biopharmaceuticals LLC and JEOL Ltd. announced their collaboration to bring innovative drug discovery platform solutions using JEOL's 800 MHz NMR. With the help of this partnership, JEOL Ltd. aspires to grow its 3D protein structure analysis base and increase its existing product line.
•   In August 2020, Thermo Fisher Scientific Inc., a global leader in providing scientific services, announced that it would facilitate access to cryo-electron microscopy (cryo-EM) by connecting pharmaceutical and biotechnology companies with contract research organizations (CROs) that provide start-up packages for this game-changing technology as a service.

Recent Developments in Global 3D Protein Structure Analysis Market

•    In February 2022, JEOL Ltd. announced the development of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM 200 II (JEM-Z200CA), dedicated to single particle analysis of proteins.
•    In November 2021, JEOL Ltd. announced the availability of "ECZ Luminous" nuclear magnetic resonance console (JNM-ECZL series). This product is the next step in spectrometer miniaturization and extended performance through state-of-the-art digital and high-frequency technologies.
•    In October 2020, Thermo Fisher Scientific Inc. introduced two ground-breaking imaging filters, i.e., the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific Selectris X Imaging Filter, which elevated cryo-electron microscopy (cryo-EM) to a new level by allowing users to view proteins at true atomic resolution.
•    In April 2021, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific E-CFEG, a significant accessory for the Thermo Scientific Krios Cryo-TEM and the company's new cold field emission gun. In comparison to other commercially available technologies, the E-four CFEG's key components work together to achieve single particle analysis (SPA) resolution levels that are unprecedented.

 

Global 3D Protein Structure Analysis Market Segments

jBb117moRNa2iBL8cifc_06_8ad23f268f2823de966247d2d6ea918a_image.png

 

Demand – Drivers and Limitations

Following are the demand drivers for the global 3D protein structure analysis market:

•    Technological Advancements in Equipment for Protein Structure Analysis
•    Increase in RD Expenditure in Drug Discovery and Development
•    Rising Focus on Automation and Miniaturization in X-Ray Crystallography Workflow

The market is expected to face some limitations too due to the following challenges:

•    Certain Instrument Limitations Pertaining to 3D Protein Structure Analysis
•    Lack of Qualified Personnel
•    High Cost and Time-Consuming Method

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

•    Bruker Corporation
•    JEOL Ltd.
•    Spectris plc
•    Thermo Fisher Scientific Inc.
•    Merck KGaA
•    Schrodinger, Inc.
•    Molecular Dimensions
•    Arinax Scientific Instrumentation.
•    Cambridge Isotope Laboratories, Inc.
•    HAMPTON RESEARCH CORP.
•    DNASTAR
•    RosettaCommons.org
•    Rigaku Corporation
•    Dassault Systemes
•    Jena Bioscience GmbH

 Get Free Sample Report - https://bisresearch.com/requestsample?id=1364type=download

Key Questions Answered in the Report

  • What are the major market drivers, challenges, and opportunities and their respective impacts in the global 3D protein structure analysis market?
  • What is the potential impact of technological advancements among the key end users, such as biopharmaceutical companies and academic and research institutes?
  • What is the current market demand along with future expected demand for the global 3D protein structure analysis market?
  • What are the key development strategies that have been implemented by the major players in order to sustain the competitive market?
  • Which potential entry barriers are expected to be faced by the companies willing to enter the global 3D protein structure analysis market?
  • How is each segment of the market expected to grow during the forecast period from 2022 to 2032 based on each segment?
  • Following are the segment types:
    • Product (Consumable, Equipment, and Software)
    • End User (Biopharmaceutical Company, Academic and Research Institute, Other End User)
    • Region (North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW))
  • Who are the leading players with significant offerings to the global 3D protein structure analysis market, and what is the expected market dominance for each of these leading players?
  • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global 3D protein structure analysis market?
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • Who are the leading computational software providers with significant offerings in the global 3D protein structure analysis market?
  • Who are the major equipment manufacturers for different technologies in the global 3D protein structure analysis market?
  • What are the growth opportunities for the companies in the region of their operation?

 

BIS Related Studies

Global Recombinant Cell Culture Supplements Market

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...